Allergen News and Research

RSS

Researchers discover how dendritic cells exchange information to amplify immune response

Using a new fluorescent biosensor they developed, researchers at Carnegie Mellon University have discovered how a key set of immune cells exchange information during their coordinated assault on invading pathogens.

24 Apr 2012

ACOEM re-releases checklist of ‘Ten Environmental Hazards You Can Live Without’

With more and more people spending a good portion of their day inside - whether at home, school, and/or in the workplace - it is important to recognize that indoor environments may contain a number of hazards. However, many of these hazards can easily be eliminated and/or controlled. To address these issues, and to commemorate the annual observance of Earth Day on April 22, the American College of Occupational and Environmental Medicine (ACOEM) has re-released its checklist of "Ten Environmental Hazards You Can Live Without."

20 Apr 2012

Study: Sharp increase in airborne pollens across Europe

When trees and plants release their pollen, millions of hay fever sufferers are affected by sneezing fits and itchy, watery eyes. Today in Germany, roughly every fourth person suffers from allergies - and this figure is set to rise. Climate change is seen as one of the factors fuelling the increase in allergic responses.

17 Apr 2012

ITC Hotels offers allergy friendly rooms

With over 100 hotels at more than 90 destinations across India, ITC Hotels offers the discerning traveler traditional Indian hospitality combined with globally benchmarked services and sustainable business practices. Adding to these initiatives, ITC partnered with PURE Global, the innovator and market leader of allergy friendly rooms worldwide.

7 Apr 2012

Crispy brand cookies may contain undeclared allergens, warns FDA

TWI Foods Inc. is voluntarily recalling several varieties of Crispy brand cookies and rusk. The Food and Drug Administration (FDA) along with the Canadian Food Inspection Agency (CFIA) and TWI Foods Inc., are warning people with allergies to milk or almonds not to consume Crispy brand cookie and rusk products. The affected products contain almonds and/or milk which are not clearly declared on the label.

6 Apr 2012

Advaxis, Karolinska Institutet enter collaboration to develop cat allergy vaccine

Advaxis, Inc.,, a leader in developing the next generation of immunotherapies for cancer and infectious diseases, announced that it has entered into a research collaboration with Professor Marianne van Hage, research group leader and Head of the Clinical Immunology and Allergy Unit and Vice Head of the Department of Medicine at Karolinska Institutet in Stockholm, Sweden.

6 Apr 2012

Brand of egg truffles recalled due to labelling error

The recall is for five batches of Heritage-brand Belgian Milk Chocolate Egg with chocolate truffles in a 270-gram package, sold exclusively through Coles supermarkets. The product contains almond, hazelnut and gluten, but these ingredients are not listed on the package due to a labeling error.

5 Apr 2012

Vaccination most promising against asthma

Asthma is a chronic inflammatory and respiratory disease caused by an abnormal reactivity to allergens in the environment. Of the several avenues of exploration that are currently being developed, vaccination appears to be the most promising approach.

5 Apr 2012

FAAN plays a crucial role in supporting peanut allergy study

Why do some children develop a peanut allergy and others don't? Researchers trying to answer this crucial question in order to learn how to prevent this life-threatening food allergy believe that being exposed to peanuts through skin early in life could be a determining factor.

4 Apr 2012

Differentiating between sneezing due to cold and allergies

One of the problems that parents may have during the springtime is deciphering whether their children's sneezing is due to a cold or allergies.

31 Mar 2012

First study to explore differential gender effects of secondhand smoke exposure

The negative health effects of early-life exposure to secondhand smoke appear to impact girls more than boys-particularly those with early-life allergic sensitization, according to new research from the University of Cincinnati (UC) College of Medicine.

27 Mar 2012

Commensal bacteria may play an important role in influencing and controlling allergic inflammation

When poet Walt Whitman wrote that we "contain multitudes," he was speaking metaphorically, but he was correct in the literal sense. Every human being carries over 100 trillion individual bacterial cells within the intestine -- ten times more cells than comprise the body itself.

26 Mar 2012

Simple and accurate test for peanut allergy

The Murdoch Children’s Research Institute and University of Melbourne researchers discovered a two-pronged blood test will confirm peanut allergies instead of putting children through risky oral food challenge tests.

21 Mar 2012

IDSA releases new rhinosinusitis guidelines

The vast majority of sinus infections are caused by viruses and should not be treated with antibiotics, suggest new guidelines released by the Infectious Diseases Society of America.

21 Mar 2012

AAFA releases new 'Spring Allergy Capital' rankings

Today is the vernal equinox – otherwise known as the official end of winter and the start of spring. But even if you didn't look at your calendar today, chances are your nose already figured it out. That's because more than 40 million Americans have nasal allergies.

20 Mar 2012

Allergy-free egg in the making

Researchers at CSIRO and experts at Geelong's Deakin University have found a way to “switch off” four egg allergens. These modified eggs could produce chickens that lay hypoallergenic eggs but the genes and DNA of the chicken would remain unaltered.

15 Mar 2012

Positive phase II trial results from Circassia's ragweed allergy therapy

Circassia Ltd, a specialty biopharmaceutical company focused on allergy, today announced that its ragweed allergy therapy has achieved positive results in a key phase II clinical trial.

8 Mar 2012

Merck announces results from AIT Phase III clinical study for ragweed allergy

Merck, known as MSD outside the United States and Canada, today announced the results from a Phase III clinical study of its investigational allergy immunotherapy tablet (AIT) for ragweed pollen.

6 Mar 2012

Merck announces success of pill against ragweed allergy

Merck & Co. announced Monday that their experimental allergy tablet reduced allergic reactions to ragweed and helped patients use less medication to treat their symptoms.

5 Mar 2012

New outcome measures may reduce disparities in children with asthma

Newly proposed asthma outcome measures will help standardize and improve results from the hundreds of millions of dollars the National Institutes of Health (NIH) spends annually to study asthma, according to the Merck Childhood Asthma Network, Inc. (MCAN), the nation's only organization focused solely on childhood asthma.

3 Mar 2012